Advisory Research’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Advisory Research’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-106,578	Closed	-$1.33M	–	443
2016 Q4	$1.33M	Buy	+106,578	New	+$1.28M	0.02%	251

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Advisory Research's ARIA Position: Q1 2017 in Review

Advisory Research sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 106,578 shares — an estimated $1.33M sold.

Advisory Research first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $1.33M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Advisory Research reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Advisory Research sold 106,578 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $1.33M.
Advisory Research first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
Advisory Research's Ariad Pharmaceuticals Inc position peaked at $1.33M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Advisory Research's 13F filing for Q1 2017, filed 15 May 2017.